Sat, Dec 27, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

$1.1bn Carlyle Fund invests into alternative asset manager Avalon Advisors

Tuesday, August 30, 2011

Randy Quarles
Opalesque Industry Update – Houston-based, $4bn wealth advisor Avalon Advisors announced on Tuesday that it had received a significant investment from private equity firm Carlyle Partners. The investment comes from Carlyle Global Financial Services Partners, which is a $1.1bn fund focused on investing into financial services companies.

In a statement released by both firms, Randy Quarles, Managing Director at Carlyle said, “We are pleased to form this partnership with Avalon. The firm has committed leadership, a talented team and an excellent track record of investment performance and client service. Avalon has deep market penetration and focused expansion plans that we look forward to supporting.”

Headquartered in Texas, Avalon Advisors was founded in 2001 and manages equity, fixed income and balanced portfolios for wealthy families, endowments, foundations, trusts and institutions across the US. It employs 25 people and has grown into one of the largest independent asset management firms in the Southwest, with nearly $4bn in client assets under management.

kb

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its